Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired . via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

v: News Feed Item

SGX Pharmaceuticals [SGXP] President and CEO to Ring The NASDAQ Stock Market Closing Bell

SGX Pharmaceuticals [SGXP] President and CEO to Ring The NASDAQ Stock Market Closing Bell

-- (MARKET WIRE) -- 03/31/06 --


Michael Grey, President and CEO of SGX Pharmaceuticals (NASDAQ: SGXP) will preside over the closing bell to celebrate its initial public offering on the NASDAQ.


NASDAQ MarketSite -- 4 Times Square -- 43rd & Broadway -- Broadcast Studio


Monday, April 3rd, 2006 at 4:00 p.m. EST

Feed Information:

The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.


To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About SGX Pharmaceuticals (NASDAQ: SGXP):

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The Company's lead product candidate, Troxatyl(TM), is currently being evaluated in a pivotal phase II/III trial for the treatment of third-line acute myelogenous leukemia, an indication for which there is currently no approved therapy or standard of care. SGX has developed a pipeline of oncology drug candidates based on its enabling, proprietary FAST(TM) drug discovery platform, including a portfolio of next generation BCR-ABL inhibitors. FAST allows for the rapid identification of novel, potent and selective small molecule compounds for well validated but challenging targets. More information on SGX's pipeline and drug discovery platform can be found at www.sgxpharma.com

Todd Myers
Email Contact

Jason Spark
Porter Novelli Life Sciences
Email Contact

NASDAQ MarketSite:
Stephanie Lowenthal

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.